Additional Funding to Support Randomized Study Evaluating Earlier Access to INTERCEPT Fibrinogen Complex in Trauma Associated Hemorrhagic Shock Patients The additional funding will support CRYO-FIRST, ...
CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (CERS) announced today that it will host an industry workshop on the benefits of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, commonly ...
Cerus Corporation (NASDAQ:CERS) is among the Best Get Rich Fast Stocks to Buy Right Now. On December 23, TheFly reported that TD Cowen views Cerus Corporation (NASDAQ:CERS)’s Intercept Fibrinogen ...
Additional Funding to Support Randomized Study Evaluating Earlier Access to INTERCEPT Fibrinogen Complex in Trauma Associated Hemorrhagic Shock Patients Cerus Corporation (Nasdaq: CERS) announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback